3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Prostatic Neoplasms
8
Polycystic Ovary Syndrome
7
Carcinoma, Non-Small-Cell Lung
6
Breast Neoplasms
6
Colorectal Neoplasms
5
Lung Neoplasms
4
Metabolic Syndrome
3
Insulin Resistance
3
Adenocarcinoma of Lung
3
Lymphoma, Large B-Cell, Diffuse
2
Glioblastoma
2
Carcinoma, Renal Cell
2
pCR Rate
1
Weight Gain
1
Thyroid Diseases
1
Thoracic Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Obesity
1
Non-alcoholic Fatty Liver Disease
1
Neoplasms
1
Neoplasm Metastasis
1
Mouth Neoplasms
1
Motor Activity
1
Melanoma
1
Lymphoma
1
Leukoplakia
1
Leukemia, Myelomonocytic, Acute
1
Interventions
Surveys and Questionnaires
1
Metformin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Death
×
Metformin
×
Clear all
NCT02319200
2017-01-11
METFOVIR
Assistance Publique - Hôpitaux de Paris
Phase 3
Terminated
11 enrolled